CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2021; 25(01): e35-e40
DOI: 10.1055/s-0039-3402495
Original Research

Mucociliary Clearance of Different Respiratory Conditions: A Clinical Study

1   Departament of Physiotherapy, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Presidente Prudente, SP, Brazil
,
Dionei Ramos
1   Departament of Physiotherapy, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Presidente Prudente, SP, Brazil
,
Bruna Spolador de Alencar Silva
1   Departament of Physiotherapy, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Presidente Prudente, SP, Brazil
,
Mariana Belon Previatto de Lima
1   Departament of Physiotherapy, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Presidente Prudente, SP, Brazil
,
Rebeca Nunes Silva
1   Departament of Physiotherapy, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Presidente Prudente, SP, Brazil
,
Carlos Augusto Camillo
2   Departament of Physiotherapy, Universidade Estadual de Londrina, Londrina, PR, Brazil
,
Ercy Mara Cipulo Ramos
1   Departament of Physiotherapy, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Presidente Prudente, SP, Brazil
› Author Affiliations
Funding This study was funded by the São Paulo Research Foundation (FAPESP, in the Portuguese acronym) (grant number 2014/11970–3).

Abstract

Introduction Mucociliary clearance (MCC) is the first line of defense of the pulmonary system. Mucociliary clearance impairment may lead to increased risk of respiratory infections, lung injury, pulmonary repair problems, chronic dysfunctions and progression of respiratory diseases.

Objective To characterize the MCC of active and passive smokers and individuals with chronic obstructive pulmonary disease (COPD) and compare the MCC behaviors between men and women of different age groups.

Methods Patients with COPD (current smokers and ex-smokers) and apparently healthy individuals (current smokers, passive smokers and nonsmokers) were evaluated. All of the subjects underwent lung function and MCC evaluation (saccharin transport test [STT]). Smokers (with or without COPD) were questioned about the smoking history.

Results A total of 418 individuals aged 16 to 82 years old, of both genders, were evaluated. The STT values of active and passive smokers were statistically higher than those of the control group (p < 0.01). Men of the control group had lower values of STT than active smokers (9.7 ± 7.1 and 15.4 ± 10.1 minute, respectively, p < 0.01). In addition, higher MCC velocity was observed in women that are current smokers (11.7 ± 6.8 minute) compared with men (15.4 ± 10.1 minute) in this group (p = 0.01). Among the younger age groups (< 50 years old), only passive smokers presented higher STT in relation to the control group.

Conclusion Passive and active smoking are factors that influence negatively the MCC, and passive smokers may present losses of this mechanism at a younger age. Additionally, male smokers present worse MCC than male nonsmokers.

Ethical Approval

All of the procedures performed in the present study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The data presented in the present study originates from other cohorts, all of which were approved by the institutional review board. (#18/2011; #07152212.0.0000.5402; and #00849812.0.0000.5402). Informed consent was obtained from all individual participants included in the study.




Publication History

Received: 22 July 2019

Accepted: 11 November 2019

Article published online:
24 April 2020

© 2020. Fundação Otorrinolaringologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Trindade SHK, de Mello Júnior JF, Mion OG. et al. Métodos de estudo do transporte mucociliar. Rev Bras Otorrinolaringol 2007; 73: 704-712
  • 2 Sears PR, Yin WN, Ostrowski LE. Continuous mucociliary transport by primary human airway epithelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 2015; 309 (02) L99-L108
  • 3 Proença de Oliveira-Maul J, Barbosa de Carvalho H, Goto DM. et al. Aging, diabetes, and hypertension are associated with decreased nasal mucociliary clearance. Chest 2013; 143 (04) 1091-1097
  • 4 Plaza Valía P, Carrión Valero F, Marín Pardo J, Bautista Rentero D, González Monte C. [Saccharin test for the study of mucociliary clearance: reference values for a Spanish population]. Arch Bronconeumol 2008; 44 (10) 540-545
  • 5 Paul P, Johnson P, Ramaswamy P, Ramadoss S, Geetha B, Subhashini AS. The effect of ageing on nasal mucociliary clearance in women: a pilot study. ISRN Pulmonol 2013; 2013: 1-5
  • 6 Puchelle E, Zahm JM, Bertrand A. Influence of age on bronchial mucociliary transport. Scand J Respir Dis 1979; 60 (06) 307-313
  • 7 Armengot M, Barona R, Garín L, Basterra J. [The influence of age, sex and circadian rhythms on the nasal mucosal in the mucociliary clearance]. An Otorrinolaringol Ibero Am 1993; 20 (06) 581-588
  • 8 Ho JC, Chan KN, Hu WH. et al. The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. Am J Respir Crit Care Med 2001; 163 (04) 983-988
  • 9 Svartengren M, Falk R, Philipson K. Long-term clearance from small airways decreases with age. Eur Respir J 2005; 26 (04) 609-615
  • 10 Gerrard CS, Gerrity TR, Yeates DB. The relationships of aerosol deposition, lung size, and the rate of mucociliary clearance. Arch Environ Health 1986; 41 (01) 11-15
  • 11 Bennett WD, Laube BL, Corcoran T. et al. Multisite comparison of mucociliary and cough clearance measures using standardized methods. J Aerosol Med Pulm Drug Deliv 2013; 26 (03) 157-164
  • 12 Nicola ML, Carvalho HB, Yoshida CT. et al. Young “healthy” smokers have functional and inflammatory changes in the nasal and the lower airways. Chest 2014; 145 (05) 998-1005
  • 13 Tilley AE, Walters MS, Shaykhiev R, Crystal RG. Cilia dysfunction in lung disease. Annu Rev Physiol 2015; 77: 379-406
  • 14 Tamashiro E, Xiong G, Anselmo-Lima WT, Kreindler JL, Palmer JN, Cohen NA. Cigarette smoke exposure impairs respiratory epithelial ciliogenesis. Am J Rhinol Allergy 2009; 23 (02) 117-122
  • 15 Lan MY, Ho CY, Lee TC, Yang AH. Cigarette smoke extract induces cytotoxicity on human nasal epithelial cells. Am J Rhinol 2007; 21 (02) 218-223
  • 16 Navarrette CR, Sisson JH, Nance E, Allen-Gipson D, Hanes J, Wyatt TA. Particulate matter in cigarette smoke increases ciliary axoneme beating through mechanical stimulation. J Aerosol Med Pulm Drug Deliv 2012; 25 (03) 159-168
  • 17 Borin A, Abib Jr E, Araujo CI, Martinez LL, Rodrigues H. Standardizing selection criteria in nasal medication studies. Rev Bras Otorrinolaringol (Engl Ed) 2009; 75 (06) 872-878
  • 18 Smith DJ, Gaffney EA, Blake JR. Modelling mucociliary clearance. Respir Physiol Neurobiol 2008; 163 (1-3): 178-188
  • 19 SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002; 4 (02) 149-159
  • 20 Sociedade Brasileira de Pneumologia e Tisiologia (SBPT). Diretrizes para testes de função pulmonar. J Pneumol 2002; 28: S1-S238
  • 21 Miller MR, Hankinson J, Brusasco V. et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005; 26 (02) 319-338
  • 22 Pereira CAC, Barreto SP, Simões JG, Pereira FWL, Gerstler JG, Nakatani J. Valores de referência para espirometria em uma amostra da população brasileira adulta. J Bras Pneumol 1992; 18: 10-22
  • 23 Ramos EM, Vanderlei LC, Ito JT. et al. Acute mucociliary clearance response to aerobic exercise in smokers. Respir Care 2015; 60 (11) 1575-1584
  • 24 Habesoglu M, Demir K, Yumusakhuylu AC, Yilmaz AS, Oysu C. Does passive smoking have an effect on nasal mucociliary clearance?. Otolaryngol Head Neck Surg 2012; 147 (01) 152-156
  • 25 Freire APCF, Ramos D, Leite MR. et al. Influence of time and frequency of passive smoking exposure on mucociliary clearance and the autonomic nervous system. Respir Care 2016; 61 (04) 453-461
  • 26 Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med 2010; 363 (23) 2233-2247
  • 27 Pagliuca G, Rosato C, Martellucci S. et al. Cytologic and functional alterations of nasal mucosa in smokers: temporary or permanent damage?. Otolaryngol Head Neck Surg 2015; 152 (04) 740-745
  • 28 Petanová J. [Smoking and immunity]. Cas Lek Cesk 2017; 156 (01) 6-8
  • 29 Jayes L, Haslam PL, Gratziou CG. et al; Tobacco Control Committee of the European Respiratory Society. SmokeHaz: Systematic reviews and meta-analyses of the effects of smoking on respiratory health. Chest 2016; 150 (01) 164-179
  • 30 Hessel J, Heldrich J, Fuller J. et al. Intraflagellar transport gene expression associated with short cilia in smoking and COPD. PLoS One 2014; 9 (01) e85453
  • 31 Ito JT, Ramos D, Lima FF. et al. Nasal mucociliary clearance in subjects with COPD after smoking cessation. Respir Care 2015; 60 (03) 399-405
  • 32 Yaghi A, Dolovich MB. Airway epithelial cell cilia and obstructive lung disease. Cells 2016; 5 (04) e40
  • 33 Yaghi A, Zaman A, Cox G, Dolovich MB. Ciliary beating is depressed in nasal cilia from chronic obstructive pulmonary disease subjects. Respir Med 2012; 106 (08) 1139-1147
  • 34 Uzeloto JS, Ramos D, Freire APCF, Christofaro DGD, Ramos EMC. Nasal mucociliary transportability of male and female smokers. Rev Bras Otorrinolaringol (Engl Ed) 2017; 17: S1808-S8694
  • 35 Di Giuda D, Galli J, Calcagni ML. et al. Rhinoscintigraphy: a simple radioisotope technique to study the mucociliary system. Clin Nucl Med 2000; 25 (02) 127-130